Almac Clinical Technologies, a unit of UK-based contract development and manufacturing firm Almac Group, has introduced an advanced interactive response technology (IRT).

‘Simplify’ is designed to accelerate the study start-up process with higher efficiency and comes with an array of configurable functionality as standard.

Almac noted that Simplify was designed for trial sponsors and CROs in need of quick and efficient stand up critical eClinical infrastructure with minimal effort or oversight.

The IRT solution offers a hassle-free, straightforward approach for deploying leading IRT capabilities in half the time compared to traditional solutions.

Almac Clinical Technologies president and managing director Valarie Higgins said: “Simplify sets itself apart from other IRT alternatives by offering the flexibility to scale the scope of your solution to at any time.

“This means that unplanned, or unexpected, protocol changes that require custom solutions can be swiftly implemented without requiring a major redesign, and are guided by our expert team of biostatistical, integration, design and support consultants.

“We’re very proud of our longstanding reputation for developing novel solutions in direct response to the pain points we have observed in the industry.”

The IRT solution is powered by Almac IXRS 3 technology, which is known for its high performance and reliability.

According to Almac, the solution also provides improved experience and usability for the users at a significantly reduced cost.

In March last year, Almac unveiled a unified clinical trial supply solution to improve experience for sponsors.